Insider Transactions in Q2 2020 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2020
|
Javier Rodriguez Director |
SELL
Open market or private sale
|
Direct |
189
-100.0%
|
$14,175
$75.5 P/Share
|
|
Jun 10
2020
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,691
-11.24%
|
$130,207
$77.07 P/Share
|
|
Jun 10
2020
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,646
+19.51%
|
-
|
|
May 05
2020
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
13,210
-47.43%
|
$1,043,590
$79.23 P/Share
|
|
May 05
2020
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,210
+16.93%
|
$422,720
$32.43 P/Share
|
|
May 05
2020
|
Gayle E Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,270
+1.73%
|
-
|
|
May 05
2020
|
Kevin E Lofton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,270
+2.49%
|
-
|
|
May 05
2020
|
Olsen Per Wold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,270
+2.22%
|
-
|
|
May 05
2020
|
Richard James Whitley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,270
+7.1%
|
-
|
|
May 05
2020
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-10.13%
|
$33,101
$79.14 P/Share
|
|
May 05
2020
|
Harish Manwani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,270
+35.43%
|
-
|
|
May 04
2020
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Open market or private sale
|
Direct |
12,264
-51.78%
|
$981,120
$80.09 P/Share
|
|
May 04
2020
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,486
+32.66%
|
$758,076
$66.36 P/Share
|
|
May 04
2020
|
John Francis Cogan Director |
SELL
Open market or private sale
|
Direct |
2,416
-4.22%
|
$195,696
$81.75 P/Share
|
|
May 04
2020
|
John Francis Cogan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,416
+4.05%
|
$45,904
$19.63 P/Share
|
|
Apr 27
2020
|
John Francis Cogan Director |
SELL
Open market or private sale
|
Direct |
2,413
-4.21%
|
$190,627
$79.9 P/Share
|
|
Apr 27
2020
|
John Francis Cogan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,413
+4.04%
|
$45,847
$19.63 P/Share
|
|
Apr 20
2020
|
John Francis Cogan Director |
SELL
Open market or private sale
|
Direct |
2,413
-4.21%
|
$200,279
$83.0 P/Share
|
|
Apr 20
2020
|
John Francis Cogan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,413
+4.04%
|
$45,847
$19.63 P/Share
|
|
Apr 13
2020
|
John Francis Cogan Director |
SELL
Open market or private sale
|
Direct |
2,413
-4.21%
|
$180,975
$75.9 P/Share
|
|
Apr 13
2020
|
John Francis Cogan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,413
+4.04%
|
$45,847
$19.63 P/Share
|
|
Apr 06
2020
|
John Francis Cogan Director |
SELL
Open market or private sale
|
Direct |
2,413
-4.21%
|
$190,627
$79.52 P/Share
|
|
Apr 06
2020
|
John Francis Cogan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,413
+4.04%
|
$45,847
$19.63 P/Share
|